Regeneron Pharmaceuticals revenue and financials

REGN · NASDAQ · USD

Compare Regeneron Pharmaceuticals
$955.47Change from previous close: +0.45%Absolute change: +$4.28

Close · November 13, 2026

In the fiscal year ended December 2025, Regeneron Pharmaceuticals reported revenue of $14.34B (+0.99% year over year). Net income was $4.5B, a net margin of 31.4%.

Annual revenue · 2025: $14.34B
  1. $4.86B2016
  2. $5.87B2017
  3. $5.15B2018
  4. $6.56B2019
  5. $8.5B2020
  6. $16.07B2021
  7. $12.17B2022
  8. $13.12B2023
  9. $14.2B2024
  10. $14.34B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+0.99%
2025 vs 2024
Net income growth
+2.09%
2025 vs 2024
Net margin
31.4%
2024: 31.1%

How Regeneron Pharmaceuticals is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue14,34314,20213,11712,17316,0728,4976,5585,1465,8724,860
Cost of revenue7,9517,1036,2555,1535,2983,767403238203195
Gross profit6,3927,1006,8627,02010,7744,7303,3433,2593,4002,508
Selling, general and administrative2,7002,9542,6312,1161,8251,3461,3421,1271,3201,178
Research and development5,8505,1324,4393,5932,8602,6472,4501,4692,0752,052
Operating income3,5783,9914,0474,7398,9473,5772,2102,5342,0801,331
EBIT3,7024,1454,2334,9948,9953,6652,2102,5342,0801,331
EBITDA4,2464,6284,6545,3359,2813,9012,4202,6832,2251,435
Interest expense43.855.273.059.457.356.930.228.225.17.2
Pre-tax income5,2314,7804,1994,8599,3263,8102,4292,5542,0791,330
Income tax7263672465201,251297313109880434
Net income4,5054,4133,9544,3388,0753,5132,1162,4441,199896
Net income to common shareholders4,5054,4133,9544,3388,0753,5132,1162,4441,199896
Basic EPS43.0740.9037.0540.5176.4032.6519.3822.6511.278.55
Diluted EPS41.4838.3434.7738.2271.9730.5218.4621.2910.347.70
Average shares (basic)105108107107106108109108106105
Average shares (diluted)109115114114112115115115116116
Dividend per share3.52—————————

Companies in the group: same industry, similar size